Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Sweeney

Showing results (21-30 of 263) with videos related to

Pageof 27
Sort By:
Oncogene|April 18, 2002
Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cellsPoornima Bhat-Nakshatri, Christopher J Sweeney, Harikrishna Nakshatri
European Urology|March 12, 2017
"Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate CancerDeclan G Murphy, Christopher J Sweeney, Bertrand Tombal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2017
Reply to Y. Zhu et alWanling Xie, Meredith M Regan, Christopher J Sweeney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2021
Metastatic Prostate Cancer: In Search of More GranularityAlok K Tewari, Silke Gillessen, Christopher J Sweeney
Trends in Molecular Medicine|January 14, 2003
Resistance in the anti-angiogenic era: nay-saying or a word of caution?Christopher J Sweeney, Kathy D Miller, George W Sledge
European Urology|November 14, 2019
Re: Rivaroxaban for Thromboprophylaxis in High-risk Ambulatory Patients with CancerChristian Daniel Fankhauser, Christopher J Sweeney, Jean M Connors
Cancer Treatment Reviews|March 19, 2015
Sequencing current therapies in the treatment of metastatic prostate cancerLoana B Valenca, Christopher J Sweeney, Mark M Pomerantz
EXS|December 25, 2004
Can tumor angiogenesis be inhibited without resistance?Kathy D Miller, Christopher J Sweeney, George W Sledge
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometryAndrea R Masters, Christopher J Sweeney, David R Jones
Journal of Cancer Research and Clinical Oncology|June 8, 2024
Spatial transcriptomics in cancer research and potential clinical impact: a narrative reviewMichael A Cilento, Christopher J Sweeney, Lisa M Butler
Pageof 27

Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
Oncogene|April 18, 2002
Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cellsPoornima Bhat-Nakshatri, Christopher J Sweeney, Harikrishna Nakshatri
European Urology|March 12, 2017
"Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate CancerDeclan G Murphy, Christopher J Sweeney, Bertrand Tombal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2017
Reply to Y. Zhu et alWanling Xie, Meredith M Regan, Christopher J Sweeney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2021
Metastatic Prostate Cancer: In Search of More GranularityAlok K Tewari, Silke Gillessen, Christopher J Sweeney
Trends in Molecular Medicine|January 14, 2003
Resistance in the anti-angiogenic era: nay-saying or a word of caution?Christopher J Sweeney, Kathy D Miller, George W Sledge
European Urology|November 14, 2019
Re: Rivaroxaban for Thromboprophylaxis in High-risk Ambulatory Patients with CancerChristian Daniel Fankhauser, Christopher J Sweeney, Jean M Connors
Cancer Treatment Reviews|March 19, 2015
Sequencing current therapies in the treatment of metastatic prostate cancerLoana B Valenca, Christopher J Sweeney, Mark M Pomerantz
EXS|December 25, 2004
Can tumor angiogenesis be inhibited without resistance?Kathy D Miller, Christopher J Sweeney, George W Sledge
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 15, 2006
The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometryAndrea R Masters, Christopher J Sweeney, David R Jones
Journal of Cancer Research and Clinical Oncology|June 8, 2024
Spatial transcriptomics in cancer research and potential clinical impact: a narrative reviewMichael A Cilento, Christopher J Sweeney, Lisa M Butler
Pageof 27